Edwards B R
Ann N Y Acad Sci. 1982;394:414-23. doi: 10.1111/j.1749-6632.1982.tb37453.x.
The total restoration of urinary concentrating ability of the DI rat given daily injections of vasopressin takes several weeks, although complete osmotic equilibrium across the collecting duct is manifest within hours. This suggests that there may be other deficiencies of the renal concentrating mechanism that, if corrected by vasopressin treatment, are corrected more slowly. I have focussed on just three possibilities. First, the morphology of the medullary interstitium is different from normal rats. Perhaps associated with this finding are alterations in the levels of medullary glycosaminoglycans which may have a role to play in water balance. Functional and morphological changes in the juxtamedullary nephrons are also evident. Second, the possibility exists that the countercurrent multiplier of the DI rat operates less efficiently than in the normal animal. Finally, reduced synthesis of PGs in the renal medulla of DI rats may also influence the concentrating mechanism, although in a favorable direction. While most (if not all) of these differences are secondary to the lack of vasopressin, in some instances it appears that it is the high water turnover (possibly the altered chemical composition of the medullary interstitium) that is the primary culprit. While the DI rat remains an excellent model for the study of water balance and the action of vasopressin, the presence of multiple defects within the system should be borne in mind. This is particularly true when comparing data obtained following acute treatment with vasopressin versus that following chronic treatment.
每天注射血管加压素的尿崩症大鼠的尿浓缩能力完全恢复需要数周时间,尽管数小时内集合管就能实现完全的渗透平衡。这表明肾浓缩机制可能还存在其他缺陷,若通过血管加压素治疗得以纠正,其纠正速度会更慢。我仅关注了三种可能性。其一,髓质间质的形态与正常大鼠不同。或许与此发现相关的是髓质糖胺聚糖水平的改变,而这可能在水平衡中发挥作用。近髓肾单位的功能和形态变化也很明显。其二,尿崩症大鼠的逆流倍增器可能不如正常动物那样高效运作。最后,尿崩症大鼠肾髓质中前列腺素合成减少也可能影响浓缩机制,尽管是朝着有利的方向。虽然这些差异大多(即便不是全部)继发于血管加压素的缺乏,但在某些情况下,似乎是高水周转率(可能是髓质间质化学成分的改变)才是主要原因。尽管尿崩症大鼠仍是研究水平衡和血管加压素作用的绝佳模型,但应牢记该系统内存在多种缺陷。在比较急性给予血管加压素治疗与慢性治疗后获得的数据时,尤其如此。